1 / 10

COVID-19 Vaccination and Type of Vaccination Lung Specialist in Jaipur

COVID-19 Vaccination and Type of Vaccination Lung Specialist in Jaipur

drnishthasingh
Download Presentation

COVID-19 Vaccination and Type of Vaccination Lung Specialist in Jaipur

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Covishield 1. The interval between 1st and 2nd doses is 12-16 weeks 2. Efficacy after the second dose can vary from 70-90% 3. People above 18 years of age can opt for this vaccine 4. Covishield is less expensive. SII is selling this vaccine at INR 300 (government) and INR 600 (private centres) 5. Covishield is more easily available

  2. Covishield

  3. Covishield 1. The Oxford-AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer. It says it is producing more than 60 million doses a month. 2. The vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus - although it can't cause illness. 3. When the vaccine is injected into a patient, it prompts the immune system to start making antibodies and primes it to attack any coronavirus infection

  4. Covishield 4. The jab is administered in two doses given between four and 12 weeks apart. It can be safely stored at temperatures of 2C to 8C and can easily be delivered in existing health care settings such as doctors' surgeries. 5. International clinical trials of the Oxford-AstraZeneca vaccine showed that when people were given a half dose and then a full dose, effectiveness hit 90%.

  5. Sputnik Vaccine • Developed by Gamaleya Research Institute of Epidemiology in association with Dr Reddy’s. Sputnik V is soon to be available in India. It is estimated that more than 18 million doses will available by August. 3rd phase trials have proved the Russian vaccine to be about 91.6% effective. As for the gap between dosages, doctors recommend waiting 21 days before a person gets the second vaccine. • Sputnik vaccine made by Body of dead corona virus .

  6. Sputnik Vaccine

  7. Sputnik Vaccine 3. Sputnik V vaccine has been given emergency use authorization in India. In India, the Russian vaccine will be produced by Dr Reddy’s Laboratories. A recent study found no strong allergies caused by Sputnik V. 4. India will produce 850 million doses of the Sputnik V vaccine every year. 5. In terms of efficacy, Sputnik V outshines both Covishield and covaxine with 91.6 % effectiveness compared to Covishield’s nearly 90% (global reports) and Covaxin’s 81% (interim 3rd phase trial results).

  8. Sputnik Vaccine 6. Sputnik will be the third vaccine to be used in India against coronavirus and will be delivered to India this month. The volume of Sputnik V vaccine production in India will be gradually increasing and may surpass 50 million doses per month 7.From May 1 onwards, everyone above the age of 18 years will be able to register for Covaxin, and Covishield (and Sputnik V when it arrives). 8. All the vaccine producers must sell 50% of their stock to the states through the free market. The remaining 50% will go to the central government.

  9. Vaccines : BCG? NYT April 5th

  10. Beneficial effects of BCG • BCG has many beneficial off –target effects including: • Reducing viral illnesses ,respiratory infection, and sepsis , and boosting immunity • WHO Report on BCG, 2017 • A 25 year study in 150,000 children in 33 countries showed BCG reduced LRTI’s by 40% in BCG vaccinated children • Jose de Castro, CID, 2015

More Related